COVID-19/SARS-CoV2: An Exploration


In response to the remarkable times we are living in, we have created this shareable, downloadable, interactive PDF Exploration document ( also found on-line HERE ), a gathering of our extensive research into the covid pandemic and its effects on us all. We hope that it will enable and inspire you to research further if you choose to.
We respect and appreciate that some of what you read and explore may challenge views you hold to be true at the moment, but we believe there are significant questions that need asking about the Covid19 narrative as it is. We all wish to make choices that will enable a full and healthy life for ourselves, our communities and our children, and that are right for now and for the future. THANK YOU"

Mike Yeadon Interview - Planet Lockdown


Professor Sucharit Bhakdi - Planet Lockdown

In this interview with Sucharit Bhakdi he discibes a study just released regarding children and masks stating that they are intolerable and unhealthy. As well he has an update on the Covid-19 vaccines. He tells how recent data is showing a higher than expected prevelence of blood clotting. Please donate to the project. Your contribution makes a real difference.

Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines


Background: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Areas of uncertainty: We assessed the efficacy of ivermectin treatment in reducing mortality, in secondary outcomes, and in chemoprophylaxis, among people with, or at high risk of, COVID-19 infection. Data sources: We searched bibliographic databases up to April 25, 2021. Two review authors sifted for studies, extracted data, and assessed risk of bias. Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses for mortality. Twenty-four randomized controlled trials involving 3406 participants met review inclusion. Therapeutic Advances: Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin (average risk ratio 0.38, 95% confidence interval 0.19–0.73; n 5 2438; I2 5 49%; moderate-certainty evidence). This result was confirmed in a trial sequential analysis using the same DerSimonian–Laird method that underpinned the unadjusted analysis. This was also robust against a trial sequential analysis using the Biggerstaff–Tweedie method. Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%). Secondary outcomes provided less certain evidence. Low-certainty evidence suggested that there may be no benefit with ivermectin for “need for mechanical ventilation,


Rainer Fuellmich Interview Planet Lockdown

Scott Jensen Interview Planet Lockdown

Claus Köhnlein, Planet Lockdown

Alexandra Herion-Caude - Full Interview Inside - Planet Lockdown

The real Tony Fauci

Virology Debunks Corona

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies


Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). Previous respiratory syncytial virus and dengue virus vaccine studies revealed human clinical safety risks related to ADE, resulting in failed vaccine trials. Here, we describe key ADE mechanisms and discuss mitigation strategies for SARS-CoV-2 vaccines and therapies in development. We also outline recently published data to evaluate the risks and opportunities for antibody-based protection against SARS-CoV-2

CDC to Convene Emergency Meeting on 226 Reports of Heart Inflammation After COVID Vaccine in People Under 30


The Centers for Disease Control and Prevention (CDC) announced Thursday it will convene an emergency meeting of its advisers on June 18 to discuss higher-than-expected reports of heart inflammation following doses of Pfizer and Moderna COVID vaccines, CBS News reported.

According to the CDC, a total of 475 cases of myocarditis or pericarditis were recorded in patients 30 and younger. The CDC identified 226 reports that might meet the agency’s “working case definition” of myocarditis and pericarditis following the shots, the agency disclosed Thursday during an FDA hearing.

Ignorance and Prejudice in Medicine


Professor Dolores Cahill says that mRNA vaccines enhances the illness and the disease.

Genetically Engineerd 'Magneto' Protein remotely controls brain and behaviour


Researchers in the United States have developed a new method for controlling the brain circuits associated with complex animal behaviours, using genetic engineering to create a magnetised protein that activates specific groups of nerve cells from a distance.

Understanding how the brain generates behaviour is one of the ultimate goals of neuroscience – and one of its most difficult questions. In recent years, researchers have developed a number of methods that enable them to remotely control specified groups of neurons and to probe the workings of neuronal circuits.

The most powerful of these is a method called optogenetics, which enables researchers to switch populations of related neurons on or off on a millisecond-by-millisecond timescale with pulses of laser light. Another recently developed method, called chemogenetics, uses engineered proteins that are activated by designer drugs and can be targeted to specific cell types.

Fauci - Public Enemy #1?

Dr. Mikael Nordfors on C***d and P*R-test lies, Tanzania without restrictions and C*rona problems


Subscribe to Medic Debate RSS